Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
You can learn more about this synergy by exploring whether CoQ10 can support energy levels for Long COVID and ME/CFS patients
Research shows the compound gives better results for specific metabolic research objectives
G., Wilbur, T
Mounjaro Medicare Part D Coverage: What You Actually Pay in 2026 At a glance Generic name / tirzepatide, a dual GIP/GLP-1 receptor agonist Brand cash price / approximately $1,023 per month without insurance Compounded tirzepatide average / roughly $249 per month Medicare Part D annual OOP cap / $2,000 (effective January 2025 under the Inflation Reduction Act) FDA-approved indications / type 2 diabetes (Mounjaro) and chronic weight management (Zepbound) Part D diabetes coverage / yes, most formularies include tirzepatide for type 2 diabetes Part D obesity coverage / limited and plan-dependent
US$ 21.74
US$ 29.68
US$ 29.95
